Interferon- therapy prolongs survival in rhesus macaque models of ebola and marburg hemorrhagic fever

Lauren M. Smith, Lisa E. Hensley, Thomas Geisbert, Joshua Johnson, Andrea Stossel, Anna Honko, Judy Y. Yen, Joan Geisbert, Jason Paragas, Elizabeth Fritz, Gene Olinger, Howard A. Young, Kathleen H. Rubins, Christopher L. Karp

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

There is a clear need for novel, effective therapeutic approaches to hemorrhagic fever due to filoviruses. Ebola virus hemorrhagic fever is associated with robust interferon (IFN)- production, with plasma concentrations of IFN- that greatly (60- to 100-fold) exceed those seen in other viral infections, but little IFN- production. While all of the type I IFNs signal through the same receptor complex, both quantitative and qualitative differences in biological activity are observed after stimulation of the receptor complex with different type I IFNs. Taken together, this suggested potential for IFN-therapy in filovirus infection. Here we show that early postexposure treatment with IFN-significantly increased survival time of rhesus macaques infected with a lethal dose of Ebola virus, although it failed to alter mortality. Early treatment with IFN- also significantly increased survival time after Marburg virus infection. IFN- may have promise as an adjunctive postexposure therapy in filovirus infection.

Original languageEnglish (US)
Pages (from-to)310-318
Number of pages9
JournalJournal of Infectious Diseases
Volume208
Issue number2
DOIs
StatePublished - Jul 15 2013

Fingerprint

Marburg Virus Disease
Ebola Hemorrhagic Fever
Macaca mulatta
Interferons
Ebolavirus
Virus Diseases
Therapeutics
Marburgvirus
Infection
Fever

Keywords

  • Filovirus
  • IFN-Ebola virus
  • Marburg virus
  • type I interferon

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy
  • Medicine(all)

Cite this

Interferon- therapy prolongs survival in rhesus macaque models of ebola and marburg hemorrhagic fever. / Smith, Lauren M.; Hensley, Lisa E.; Geisbert, Thomas; Johnson, Joshua; Stossel, Andrea; Honko, Anna; Yen, Judy Y.; Geisbert, Joan; Paragas, Jason; Fritz, Elizabeth; Olinger, Gene; Young, Howard A.; Rubins, Kathleen H.; Karp, Christopher L.

In: Journal of Infectious Diseases, Vol. 208, No. 2, 15.07.2013, p. 310-318.

Research output: Contribution to journalArticle

Smith, LM, Hensley, LE, Geisbert, T, Johnson, J, Stossel, A, Honko, A, Yen, JY, Geisbert, J, Paragas, J, Fritz, E, Olinger, G, Young, HA, Rubins, KH & Karp, CL 2013, 'Interferon- therapy prolongs survival in rhesus macaque models of ebola and marburg hemorrhagic fever', Journal of Infectious Diseases, vol. 208, no. 2, pp. 310-318. https://doi.org/10.1093/infdis/jis921
Smith, Lauren M. ; Hensley, Lisa E. ; Geisbert, Thomas ; Johnson, Joshua ; Stossel, Andrea ; Honko, Anna ; Yen, Judy Y. ; Geisbert, Joan ; Paragas, Jason ; Fritz, Elizabeth ; Olinger, Gene ; Young, Howard A. ; Rubins, Kathleen H. ; Karp, Christopher L. / Interferon- therapy prolongs survival in rhesus macaque models of ebola and marburg hemorrhagic fever. In: Journal of Infectious Diseases. 2013 ; Vol. 208, No. 2. pp. 310-318.
@article{5903ef8b990b4c47a234c684c4310c9f,
title = "Interferon- therapy prolongs survival in rhesus macaque models of ebola and marburg hemorrhagic fever",
abstract = "There is a clear need for novel, effective therapeutic approaches to hemorrhagic fever due to filoviruses. Ebola virus hemorrhagic fever is associated with robust interferon (IFN)- production, with plasma concentrations of IFN- that greatly (60- to 100-fold) exceed those seen in other viral infections, but little IFN- production. While all of the type I IFNs signal through the same receptor complex, both quantitative and qualitative differences in biological activity are observed after stimulation of the receptor complex with different type I IFNs. Taken together, this suggested potential for IFN-therapy in filovirus infection. Here we show that early postexposure treatment with IFN-significantly increased survival time of rhesus macaques infected with a lethal dose of Ebola virus, although it failed to alter mortality. Early treatment with IFN- also significantly increased survival time after Marburg virus infection. IFN- may have promise as an adjunctive postexposure therapy in filovirus infection.",
keywords = "Filovirus, IFN-Ebola virus, Marburg virus, type I interferon",
author = "Smith, {Lauren M.} and Hensley, {Lisa E.} and Thomas Geisbert and Joshua Johnson and Andrea Stossel and Anna Honko and Yen, {Judy Y.} and Joan Geisbert and Jason Paragas and Elizabeth Fritz and Gene Olinger and Young, {Howard A.} and Rubins, {Kathleen H.} and Karp, {Christopher L.}",
year = "2013",
month = "7",
day = "15",
doi = "10.1093/infdis/jis921",
language = "English (US)",
volume = "208",
pages = "310--318",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Interferon- therapy prolongs survival in rhesus macaque models of ebola and marburg hemorrhagic fever

AU - Smith, Lauren M.

AU - Hensley, Lisa E.

AU - Geisbert, Thomas

AU - Johnson, Joshua

AU - Stossel, Andrea

AU - Honko, Anna

AU - Yen, Judy Y.

AU - Geisbert, Joan

AU - Paragas, Jason

AU - Fritz, Elizabeth

AU - Olinger, Gene

AU - Young, Howard A.

AU - Rubins, Kathleen H.

AU - Karp, Christopher L.

PY - 2013/7/15

Y1 - 2013/7/15

N2 - There is a clear need for novel, effective therapeutic approaches to hemorrhagic fever due to filoviruses. Ebola virus hemorrhagic fever is associated with robust interferon (IFN)- production, with plasma concentrations of IFN- that greatly (60- to 100-fold) exceed those seen in other viral infections, but little IFN- production. While all of the type I IFNs signal through the same receptor complex, both quantitative and qualitative differences in biological activity are observed after stimulation of the receptor complex with different type I IFNs. Taken together, this suggested potential for IFN-therapy in filovirus infection. Here we show that early postexposure treatment with IFN-significantly increased survival time of rhesus macaques infected with a lethal dose of Ebola virus, although it failed to alter mortality. Early treatment with IFN- also significantly increased survival time after Marburg virus infection. IFN- may have promise as an adjunctive postexposure therapy in filovirus infection.

AB - There is a clear need for novel, effective therapeutic approaches to hemorrhagic fever due to filoviruses. Ebola virus hemorrhagic fever is associated with robust interferon (IFN)- production, with plasma concentrations of IFN- that greatly (60- to 100-fold) exceed those seen in other viral infections, but little IFN- production. While all of the type I IFNs signal through the same receptor complex, both quantitative and qualitative differences in biological activity are observed after stimulation of the receptor complex with different type I IFNs. Taken together, this suggested potential for IFN-therapy in filovirus infection. Here we show that early postexposure treatment with IFN-significantly increased survival time of rhesus macaques infected with a lethal dose of Ebola virus, although it failed to alter mortality. Early treatment with IFN- also significantly increased survival time after Marburg virus infection. IFN- may have promise as an adjunctive postexposure therapy in filovirus infection.

KW - Filovirus

KW - IFN-Ebola virus

KW - Marburg virus

KW - type I interferon

UR - http://www.scopus.com/inward/record.url?scp=84878907971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878907971&partnerID=8YFLogxK

U2 - 10.1093/infdis/jis921

DO - 10.1093/infdis/jis921

M3 - Article

C2 - 23255566

AN - SCOPUS:84878907971

VL - 208

SP - 310

EP - 318

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 2

ER -